Trials / Completed
CompletedNCT03680196
The Effect of Botulinum Toxin Injection at Hip Adductor Muscles in Patients With Spastic Cerebral Palsy, Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Ju Seok Ryu · Academic / Other
- Sex
- All
- Age
- 2 Years – 10 Years
- Healthy volunteers
- Not accepted
Summary
In children with cerebral palsy, secondary problems lead to hip dislocation. the purpose of this study is to find out the effects of botulinum toxin A on hip joint dislocation in cerebral palsy patients.
Detailed description
* Design: Prospective study * Inclusion criteria of patient group: who has a cerebral palsy and GMFCS level 3,4,5 * Intervention: applied medication Botulinum A injection (meditox 200unit) * Main outcome measures: The investigators will measure for finding evidence by checking the x-ray photograph, hip adductor and muscles pressure test and electromyography(EMG test) test of hip adductor, abductor and spine muscles.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | medication Botulinum A injection. | In cerebral palsy patients, Botulinum toxin within the allowable dose of 16 U / kg per body weight will injected into both adductor longus, adductor magnus muscle at 3 U / kg, adductor brevis, and gracilis muscle at a dose of 1 U / kg. |
Timeline
- Start date
- 2018-12-06
- Primary completion
- 2020-09-01
- Completion
- 2021-08-30
- First posted
- 2018-09-21
- Last updated
- 2021-11-08
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03680196. Inclusion in this directory is not an endorsement.